Lumentum Holdings Inc.: Form 10-Q for the period ended Dec 31, 2022
Filed with the SEC on Feb 9, 2023 and accepted by EDGAR at Feb 9, 2023, 14:25 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-10-02 to 2022-12-31 | $506.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2022-07-03 to 2022-12-31 | $1.01bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Gross profit | 3 months2022-10-02 to 2022-12-31 | $166.2m | us-gaap:GrossProfit |
| Gross profit | 6 months2022-07-03 to 2022-12-31 | $367.4m | us-gaap:GrossProfit |
| Research and development | 3 months2022-10-02 to 2022-12-31 | $75.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2022-07-03 to 2022-12-31 | $148.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-10-02 to 2022-12-31 | $98.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2022-07-03 to 2022-12-31 | $204.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-10-02 to 2022-12-31 | −$21.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2022-07-03 to 2022-12-31 | −$8.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-10-02 to 2022-12-31 | $8.9m | us-gaap:InterestExpense |
| Interest expense | 6 months2022-07-03 to 2022-12-31 | $17.4m | us-gaap:InterestExpense |
| Income tax | 3 months2022-10-02 to 2022-12-31 | $4.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2022-07-03 to 2022-12-31 | $23.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-10-02 to 2022-12-31 | −$31.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-07-03 to 2022-12-31 | −$32.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-10-02 to 2022-12-31 | −$0.46 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2022-07-03 to 2022-12-31 | −$0.47 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-10-02 to 2022-12-31 | −$0.46 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2022-07-03 to 2022-12-31 | −$0.47 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-10-02 to 2022-12-31 | 68,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2022-07-03 to 2022-12-31 | 68,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2022-07-03 to 2022-12-31 | $115.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2022-07-03 to 2022-12-31 | $62.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2022-07-03 to 2022-12-31 | $35.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-12-31 | $592.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-31 | $2.49bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $4.42bn | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $814.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-31 | $2.87bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-12-31 | $1.90bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2022-12-31 | $420.7m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2022-12-31 | $1.54bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-23-002880. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.